πŸ‡ΊπŸ‡Έ FDA
Patent

US 12071468

Purification of Factor VIII subspecies

granted A61KA61K38/00

Quick answer

US patent 12071468 (Purification of Factor VIII subspecies) held by Takeda Pharmaceutical Company Limited expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00